Jing Zhu

Jing Zhu is the Vice President, Nucleic Acid & Viral Vector Technology, at ReciBioPharm, overseeing process development activities and technology platform establishment. He has 15+ years of experience in process and analytical development, chemistry manufacturing controls (CMC) program steering within the pharmaceutical industry.

Prior to joining ReciBioParm, Jing has been at various leadership roles crossing biotech pharma and vendor companies at gene therapy fields. He led the R&D efforts on multiple commercial purification solutions for ATMPs.